|
The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on the information reviewed, there is no indication of a product quality issue.The reported patient effect of angina is listed in the xience sierra, everolimus eluting coronary stent system (eecss), electronic instructions for use as a known patient effect of coronary stenting procedures.A conclusive cause for the reported patient effect, and the relationship to the product, if any, cannot be determined; however, the reported treatment appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
|
It was reported that the patient presented with unstable angina and atherosclerotic heart disease before the initial procedure.Two xience sierra stents (4x15mm and 3.25x18mm) were implanted on (b)(6) 2021.On (b)(6) 2021, the patient was re-admitted with unstable angina.Unspecified treatment was performed, and the final patient outcome is unknown.No additional information was provided.
|